On Thursday, there were plenty of stocks that managed to make notable gains and one of those was the Regen BioPharma Inc (OTC: RGBP) stock.
The Regen stock was in focus among many investors yesterday and the stock rallied by as high as 157% on the back of massive trading volumes. Despite that, it should be noted that there was no news with regards to the company that could have resulted in such frenetic trading in the Regen stock.
The company is working on projects that could advance novel technologies fairly quickly. At this point in time, Regen is working on a range of small molecule therapies that could be deployed to treat cancer and other diseases. It is clear that Regen has decided to go after a range of ailments and medical disorders, which makes the company fairly intriguing. However, investors need to look out for any fresh news about the company before making any move.
Finance and Entertainment Reporter
Richard is a bottle of wine – the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.